Exchange Select Nicotine Lozenge
Product Images NDC 55301-617

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Exchange Select Nicotine (NDC 55301-617). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Army & Air Force Exchange Service, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Wallet_card (Image 01)

Wallet_card (Image 01)
The text describes a wallet card that provides contact information for several organizations that can offer help related to lung health, cancer, and heart health. It also suggests reaching out to a "Quitting Buddy" or a friend who has successfully quit a negative habit.*
FDA Label Image

Wallet‑_card (Image 02)

FDA Label Image

Smoke_free_logo (Image 03)

FDA Label Image

Upc_example (Image 04)

Upc_example (Image 04)
The text is not-available.*
FDA Label Image

Stickers (Image 05)

Stickers (Image 05)
This text appears to be a set of reminders to be placed on a calendar for someone who is quitting smoking. It suggests taking a lozenge every 1-2 hours during the first week (quit date), increasing the time between lozenges to every 2-4 hours in week 3, then to every 4-8 hours in week 7. Another reminder is given for week 10, with no specific recommendation.*
FDA Label Image

Image 06

Image 06
This product is a pack of 144 mint-flavored lozenges, each containing 2mg of an substance that can help individuals quit smoking. The packaging includes 6 QuitTube® containers, each containing 24 lozenges. The text also mentions a guide for users, but it's not clear how to obtain it.*
FDA Label Image

Image 07

Image 07
This is a drug fact sheet for Nicotine Polacrilex lozenges, which are an aid to stop smoking. The lozenges contain 2mg of nicotine polacrilex and are intended to reduce symptoms associated with quitting smoking, including nicotine cravings. The fact sheet includes information about warnings and directions, including when to use the lozenges and how often, how to take them, and how much to use. The product is not for use by individuals under 18 years of age. The fact sheet also includes information about inactive ingredients and contact information for questions or comments. The product is sold by the Perrigo Company and is not associated with Nicorete® Lozenge.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.